L-Thyroxin

Levothyroxine sodium, the active ingredient in L-Thyroxin, is a thyroid hormone presented as an oral tablet for oral use. It replaces deficient endogenous thyroid hormone, helping to normalize metabolic processes in patients with hypothyroidism, goiter, or those requiring thyroid hormone suppression therapy.

GNH USA supplies L-Thyroxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

L-Thyroxin (levothyroxine sodium) is used in thyroid hormone replacement therapy to address conditions related to low thyroid hormone production.

- Hypothyroidism: restores normal thyroid hormone levels, improving metabolic rate and symptom control. - Goiter: reduces thyroid‑stimulating hormone stimulation, helping to shrink an enlarged thyroid gland. - Thyroid hormone suppression therapy: provides adequate hormone levels to suppress TSH in patients at risk of thyroid tissue growth or malignancy.

Oral levothyroxine may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Headache: mild to moderate discomfort. - Insomnia: difficulty falling or staying asleep. - Palpitations: sensation of rapid or irregular heartbeat. - Weight loss: unintended reduction in body weight. - Heat intolerance: increased sensitivity to warm temperatures.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm that may require medical attention. - Angina pectoris: chest pain due to reduced coronary blood flow. - Osteoporosis: decreased bone mineral density with long‑term overtreatment. - Hyperthyroidism symptoms: tremor, anxiety, or sweating indicating excess hormone. - Allergic reaction: rash, itching, or swelling that may progress to anaphylaxis.

When prescribing L-Thyroxin, clinicians should consider several safety and handling precautions. - Dose adjustment: titrate based on TSH levels and clinical response. - Cardiovascular disease: monitor closely in patients with angina, arrhythmias, or recent myocardial infarction. - Pregnancy: maintain therapy as untreated hypothyroidism poses greater risk to mother and fetus. - Elderly patients: start with lower doses to avoid overtreatment. - Drug interactions: separate administration from calcium, iron, or antacids by at least 4 hours. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Levothyroxine can interact with several medicines, affecting its absorption or hormonal activity.

Major Interactions (Avoid): - Calcium supplements: reduce levothyroxine absorption; avoid co‑administration. - Iron salts: markedly decrease absorption; separate dosing by at least 4 hours. - Cholestyramine and other bile‑acid sequestrants: bind levothyroxine and lower its bioavailability. - Rifampin: induces hepatic enzymes, increasing levothyroxine clearance.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): levothyroxine may enhance anticoagulant effect, requiring INR monitoring. - Estrogen therapy or oral contraceptives: may increase levothyroxine requirement. - Antidepressants (e.g., SSRIs): may alter thyroid hormone metabolism, necessitating TSH checks.